Clinical Trials Browser

Neoplasms × Neoadjuvant Therapy × 90 days × Clear all

NCT06417190 2026-05-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Phase 2 Recruiting

Neoplasms